In our glaucoma model, PSD95 immunolabeling is reduced in the RGC layer and IPL of hypertensive eyes in a pattern similar to that observed in the DBA/2J glaucoma mouse model where a decline in PSD95 indicates synaptic loss [21]. This evidence concerns the gene DLG4 and glaucoma.